Latest Listings And Ipos News

Wellnex Life has negotiated a delayed and reduced-cost payment arrangement for its Pain Away acquisition, aligning with its upcoming London Stock Exchange dual listing plans. The move supports the company’s growth momentum following record revenues from Pain Away.

Golden State Mining's December Quarterly Report reveals promising exploration progress with three new gold target areas identified near the 11.2Moz Hemi deposit, alongside encouraging assay results from Canning Hill and planned drilling at Southern Cross East.

Lithium Energy Limited has received a US$6 million second deposit from CNGR Netherlands, marking a key milestone in the US$63 million sale of its Solaroz Lithium Brine Project. Shareholder approval has made the amended sale agreement unconditional, setting the stage for phased completion in 2025 and 2026.

Nimy Resources has addressed an ASX inquiry regarding recent spikes in its share price and trading volume, confirming no undisclosed information but highlighting ongoing work on its maiden JORC Exploration Target for gallium.

Centrex Limited has updated the timetable for its $10.4 million Entitlement Offer, with the offer opening on 28 January and closing on 19 February 2025. The company aims to bolster its position in sustainable agriculture through this capital raise.

Xanadu Mines has lodged a comprehensive NI 43-101 technical report for its Kharmagtai Copper-Gold Project, revealing key differences in production and economic outcomes compared to earlier ASX disclosures due to regulatory standards.

Wellard Limited has disclosed the binding sale of its last livestock vessel, the M/V Ocean Drover, for US$50 million, with plans to return the net proceeds to shareholders pending approval.

Askari Metals has closed a $350,000 strategic placement with Celtic Finance Corp. to advance its growing uranium portfolio in Tanzania, shifting away from a previously planned Rights Issue.

Immuron Limited reports a striking 70% quarter-on-quarter increase in Travelan® sales, driven by expanded pharmacy distribution in Australia and North America.

Spheria Emerging Companies Limited has declared a fully franked quarterly dividend of 3.5 cents per share, reflecting its commitment to increased shareholder returns following a robust portfolio performance in Q4 2024.

Raiden Resources Limited has affirmed that the final assay results from its Andover South Project are material to its share price, following a detailed disclosure and trading halt process in early January 2025.

Artrya Limited has responded to an ASX price query following a notable surge in its share price, confirming no undisclosed information and adherence to continuous disclosure rules.